Patents Assigned to THERATECHONOLGIES INC.
  • USE OF PROTEASE INHIBITORS AND GRF MOLECULES IN COMBINATION THERAPY
    Publication number: 20100267635
    Abstract: Combination therapies comprising a protease inhibitor and a growth hormone (GH)-inducing compound (such as a GRF molecule) are described, in which there are no or substantially no drug interactions.
    Type: Application
    Filed: April 20, 2010
    Publication date: October 21, 2010
    Applicant: THERATECHONOLGIES INC.
    Inventor: CHRISTIAN MARSOLAIS